Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
0.960
-0.017 (-1.73%)
Nov 21, 2024, 10:08 AM EST - Market open
Femasys Market Cap
Femasys has a market cap or net worth of $21.35 million as of November 21, 2024. Its market cap has decreased by -1.73% in one year.
Market Cap
21.35M
Enterprise Value
21.35M
1-Year Change
-1.73%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $21.35M, a decrease of -86.04%. That is a compound annual growth rate of -43.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 21.72M | 2.90% |
| Dec 29, 2023 | 21.11M | 98.53% |
| Dec 30, 2022 | 10.63M | -76.90% |
| Dec 31, 2021 | 46.02M | -69.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 22.58M |
| NeuroOne Medical Technologies | 22.46M |
| AEON Biopharma | 22.27M |
| Bolt Biotherapeutics | 21.81M |
| BriaCell Therapeutics | 21.75M |
| Cadrenal Therapeutics | 21.70M |
| XTL Biopharmaceuticals | 21.45M |
| Spectral AI | 21.45M |